A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With Panic Disorder
PHASE4CompletedINTERVENTIONAL
Enrollment
27
Participants
Timeline
Start Date
May 31, 2015
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
Conditions
Panic Disorder
Interventions
DRUG
Vortioxetine
Vortioxetine 5-20mg
Trial Locations (1)
95401
Siyan Clinical Corporation, Santa Rosa
All Listed Sponsors
lead
Siyan Clinical Corporation
OTHER
NCT02395510 - A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With Panic Disorder | Biotech Hunter | Biotech Hunter